ArticleFrontiers in pharmacology2019

CXCR4 Antagonism Reduces Cardiac Fibrosis and Improves Cardiac Performance in Dilated Cardiomyopathy.

Po-Yin Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.